Evogene Ltd
EVGN1.080USD
-0.020-1.82%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
9.41MMarket Cap
LossP/E TTM
More Details of Evogene Ltd Company
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Evogene Ltd Info
Ticker SymbolEVGN
Company nameEvogene Ltd
IPO dateJun 11, 2007
CEOEmber (Brian)
Number of employees117
Security typeOrdinary Share
Fiscal year-endJun 11
Address13 Gad Feinstein Street
CityREHOVOT
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code7638517
Phone97289311900
Websitehttps://evogene.com/
Ticker SymbolEVGN
IPO dateJun 11, 2007
CEOEmber (Brian)
Company Executives of Evogene Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Ms. Dorit Kreiner
Ms. Dorit Kreiner
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Mr. Mark Kapel
Mr. Mark Kapel
Executive Vice President - Technology
Executive Vice President - Technology
--
--
Mr. Ziv Kop
Mr. Ziv Kop
Independent Director
Independent Director
--
--
Prof. Adrian Percy
Prof. Adrian Percy
Independent Director
Independent Director
--
--
Dr. Elran Hilel Haber
Dr. Elran Hilel Haber
Chief Executive Officer of Biomica Limited
Chief Executive Officer of Biomica Limited
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Ms. Dorit Kreiner
Ms. Dorit Kreiner
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2024
FY2018
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
Other
4.00M
47.00%
United States
3.92M
46.00%
Israel
595.77K
7.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Feb 1
Updated: Sun, Feb 1
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Recanati (Leon Yehuda)
0.96%
Citadel Advisors LLC
0.66%
Jane Street Capital, L.L.C.
0.45%
Morgan Stanley & Co. LLC
0.35%
Two Sigma Investments, LP
0.13%
Other
97.45%
Shareholders
Shareholders
Proportion
Recanati (Leon Yehuda)
0.96%
Citadel Advisors LLC
0.66%
Jane Street Capital, L.L.C.
0.45%
Morgan Stanley & Co. LLC
0.35%
Two Sigma Investments, LP
0.13%
Other
97.45%
Shareholder Types
Shareholders
Proportion
Individual Investor
0.96%
Research Firm
0.94%
Hedge Fund
0.79%
Investment Advisor/Hedge Fund
0.17%
Investment Advisor
0.14%
Other
97.00%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
51
144.62K
9.61%
--
2025Q3
53
144.62K
9.93%
--
2025Q2
54
144.62K
9.94%
-290.86K
2025Q1
54
436.41K
15.76%
-409.22K
2024Q4
55
411.93K
12.75%
-150.59K
2024Q3
55
562.52K
10.21%
+159.81K
2024Q2
56
414.42K
108.89%
-12.34K
2024Q1
61
426.75K
10.84%
-122.17K
2023Q4
68
460.98K
18.51%
-27.27K
2023Q3
74
506.57K
13.57%
+395.44K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Recanati (Leon Yehuda)
83.89K
0.96%
--
--
Mar 17, 2025
Citadel Advisors LLC
57.58K
0.66%
+36.21K
+169.43%
Sep 30, 2025
Jane Street Capital, L.L.C.
39.42K
0.45%
+24.40K
+162.42%
Sep 30, 2025
Morgan Stanley & Co. LLC
30.32K
0.35%
+15.16K
+99.95%
Sep 30, 2025
Two Sigma Investments, LP
11.41K
0.13%
-9.68K
-45.91%
Sep 30, 2025
BNP Paribas Securities Corp. North America
11.23K
0.13%
-2.89K
-20.45%
Sep 30, 2025
P&S Vermögensberatungs AG Performance & Sicherheit
10.00K
0.11%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
4.20K
0.05%
--
--
Nov 30, 2025
UBS Financial Services, Inc.
1.20K
0.01%
-5.53K
-82.15%
Sep 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
Date
Ex-dividend Date
Type
Ratio
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
